Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Open Label, Roll Over Study of the Long Term Tolerability, Safety and Efficacy of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis

NCT01170065 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT01170065
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01170065 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Open Label, Roll Over Study of the Long Term Tolerability, Safety and Efficacy of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
Lead sponsor
Boehringer Ingelheim
Phase
Phase 2
Overall status
Completed
Start date
June 25, 2010
Completion date
September 26, 2016
Enrollment
198 (actual)
Sites
57

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary fibrosis